AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
SKIN NECROSIS AT THE INJECTION SITE INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN - CASE-REPORT AND REVIEW
Authors: SANTAMARIA A ROMANI J SOUTO JC LOPEZ A MATEO J FONTCUBERTA J
Citation: A. Santamaria et al., SKIN NECROSIS AT THE INJECTION SITE INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN - CASE-REPORT AND REVIEW, Dermatology, 196(2), 1998, pp. 264-265
THE PROTHROMBIN 20210A ALLELE IS THE MOST PREVALENT GENETIC RISK FACTOR FOR VENOUS THROMBOEMBOLISM IN THE SPANISH POPULATION
Authors: SOUTO JC COLL I LLOBET D DELRIO E OLIVER A MATEO J BORRELL M FONTCUBERTA J
Citation: Jc. Souto et al., THE PROTHROMBIN 20210A ALLELE IS THE MOST PREVALENT GENETIC RISK FACTOR FOR VENOUS THROMBOEMBOLISM IN THE SPANISH POPULATION, Thrombosis and haemostasis, 80(3), 1998, pp. 366-369
SHORT-COURSE THROMBOLYSIS AS THE FIRST-LINE OF THERAPY FOR CARDIAC-VALVE THROMBOSIS
Authors: MANTEIGA R SOUTO JC ALTES A MATEO J ARIS A DOMINGUEZ JM BORRAS X CARRERAS F FONTCUBERTA J
Citation: R. Manteiga et al., SHORT-COURSE THROMBOLYSIS AS THE FIRST-LINE OF THERAPY FOR CARDIAC-VALVE THROMBOSIS, Journal of thoracic and cardiovascular surgery, 115(4), 1998, pp. 780-784
OPTIMIZATION OF GLYCEMIC CONTROL NORMALIZES INCREASED TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN TYPE-1 DIABETIC-PATIENTS
Authors: RIGLA M MATEO J FONTCUBERTA J FELICES R SOUTO JC POU JU PEREZ A
Citation: M. Rigla et al., OPTIMIZATION OF GLYCEMIC CONTROL NORMALIZES INCREASED TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN TYPE-1 DIABETIC-PATIENTS, Diabetes, 47, 1998, pp. 1319-1319
DETECTION OF 2 NEW POLYMORPHISMS BY PCR-SSCP ANALYSIS OF THE HISTIDINE-RICH GLYCOPROTEIN GENE IN 3 FAMILIES WITH ABNORMAL PLASMA HRG LEVELS
Authors: HENNIS BC FALKON L SOUTO JC WAKABAYASHI S KOIDE T LLOBET D TIRADO I FONTCUBERTA J
Citation: Bc. Hennis et al., DETECTION OF 2 NEW POLYMORPHISMS BY PCR-SSCP ANALYSIS OF THE HISTIDINE-RICH GLYCOPROTEIN GENE IN 3 FAMILIES WITH ABNORMAL PLASMA HRG LEVELS, FIBRINOLYSIS & PROTEOLYSIS, 11(5-6), 1997, pp. 279-285
RESULTS OF PROS1 GENE ANALYSIS IN 17 SPANISH FAMILIES WITH DIFFERENT TYPES OF PROTEIN-S DEFICIENCY
Authors: ESPINOSAPARRILLA Y MORELL M TIRADO I SOUTO JC BORRELL M ESTIVILL X SALA N
Citation: Y. Espinosaparrilla et al., RESULTS OF PROS1 GENE ANALYSIS IN 17 SPANISH FAMILIES WITH DIFFERENT TYPES OF PROTEIN-S DEFICIENCY, Thrombosis and haemostasis, 1997, pp. 656-656
ABSENCE OF LINKAGE BETWEEN TYPE-III PROTEIN-S DEFICIENCY AND THE PROS1 AND C4BP GENES IN FAMILIES CARRYING THE PS HEERLEN ALLELE
Authors: ESPINOSAPARRILLA Y MORELL M SOUTO JC HEINESUNER D BORRELL M TIRADO I VOLPINI V ESTIVILL X SALA N
Citation: Y. Espinosaparrilla et al., ABSENCE OF LINKAGE BETWEEN TYPE-III PROTEIN-S DEFICIENCY AND THE PROS1 AND C4BP GENES IN FAMILIES CARRYING THE PS HEERLEN ALLELE, Thrombosis and haemostasis, 1997, pp. 758-758
PREVALENCE OF FACTOR-V-LEIDEN (FV R506Q) IN SPANISH FAMILIES WITH HEREDITARY DEFICIENCIES OF HEMOSTATIC PROTEINS
Authors: TIRADO I LLOBET D SORIA JM COLL I MARTINEZ E BORRELL M MATEO J SOUTO JC MORELL M SALA N FONTCUBERTA J
Citation: I. Tirado et al., PREVALENCE OF FACTOR-V-LEIDEN (FV R506Q) IN SPANISH FAMILIES WITH HEREDITARY DEFICIENCIES OF HEMOSTATIC PROTEINS, Thrombosis and haemostasis, 1997, pp. 915-915
NORMAL ACTIVATED PROTEIN-C RESPONSE HAS A LARGE GENETIC COMPONENT
Authors: BLANGERO J SOUTO JC BORRELL M MATEO J TIRADO I ALMASY L STONE WH FONTCUBERTA J
Citation: J. Blangero et al., NORMAL ACTIVATED PROTEIN-C RESPONSE HAS A LARGE GENETIC COMPONENT, Thrombosis and haemostasis, 1997, pp. 920-920
GENETIC-FACTORS INFLUENCE QUANTITATIVE VARIATION IN TISSUE FACTOR PATHWAY INHIBITOR
Authors: BLANGERO J SOUTO JC BORRELL M MATEO J LLOBET D ALMASY L STONE WH FONTCUBERTA J
Citation: J. Blangero et al., GENETIC-FACTORS INFLUENCE QUANTITATIVE VARIATION IN TISSUE FACTOR PATHWAY INHIBITOR, Thrombosis and haemostasis, 1997, pp. 1666-1666
SCREENING OF 1,456-G-]T MUTATION IN THROMBOMODULIN GENE IN PATIENTS WITH THROMBOSIS
Authors: LLOBET D SOUTO JC MATEO J MURILLO J COLL I VALLVE C FELICES R URRUTIA T BORRELL M FONTCUBERTA J
Citation: D. Llobet et al., SCREENING OF 1,456-G-]T MUTATION IN THROMBOMODULIN GENE IN PATIENTS WITH THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 2163-2163
ABSENCE OF LINKAGE BETWEEN TYPE-III PROTEIN-S DEFICIENCY AND THE PROS1 AND C4BP GENES IN FAMILIES CARRYING THE PROTEIN-S HEERLEN ALLELE
Authors: ESPINOSAPARRILLA Y MORELL M SOUTO JC BORRELL M HEINESUNER D TIRADO I VOLPINI V ESTIVILL X SALA N
Citation: Y. Espinosaparrilla et al., ABSENCE OF LINKAGE BETWEEN TYPE-III PROTEIN-S DEFICIENCY AND THE PROS1 AND C4BP GENES IN FAMILIES CARRYING THE PROTEIN-S HEERLEN ALLELE, Blood, 89(8), 1997, pp. 2799-2806
PUBLIC-HEALTH APPROACH TO ACTIVATED PROTEIN-C RESISTANCE ESSAY - REPLY
Authors: ALTES A SOUTO JC FONTCUBERTA J
Citation: A. Altes et al., PUBLIC-HEALTH APPROACH TO ACTIVATED PROTEIN-C RESISTANCE ESSAY - REPLY, American journal of obstetrics and gynecology, 177(5), 1997, pp. 1272-1272
ACTIVATED PROTEIN-C RESISTANCE ASSAY WHEN APPLIED IN THE GENERAL-POPULATION
Authors: ALTES A SOUTO JC MATEO J BORRELL M FONTCUBERTA J
Citation: A. Altes et al., ACTIVATED PROTEIN-C RESISTANCE ASSAY WHEN APPLIED IN THE GENERAL-POPULATION, American journal of obstetrics and gynecology, 176(2), 1997, pp. 358-359
THE GENETIC-ANALYSIS OF FAMILIES WITH TYPE-I AND OR TYPE-III PROTEIN-S DEFICIENCY REVEALS THE COMPLEXITY UNDERLYING TYPE-III DEFICIENCY/
Authors: ESPINOSAPARRILLA Y MORELL M SOUTO JC BORRELL M FONTCUBERTA J ESTIVILL X SALA N
Citation: Y. Espinosaparrilla et al., THE GENETIC-ANALYSIS OF FAMILIES WITH TYPE-I AND OR TYPE-III PROTEIN-S DEFICIENCY REVEALS THE COMPLEXITY UNDERLYING TYPE-III DEFICIENCY/, American journal of human genetics, 61(4), 1997, pp. 1945-1945
A NEW CASE OF HEREDITARY HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY WITH FAMILIAL THROMBOPHILIA
Authors: SOUTO JC GARI M FALKON L FONTCUBERTA J
Citation: Jc. Souto et al., A NEW CASE OF HEREDITARY HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY WITH FAMILIAL THROMBOPHILIA, Thrombosis and haemostasis, 75(2), 1996, pp. 374-375
ORAL-SURGERY IN ANTICOAGULATED PATIENTS WITHOUT REDUCING THE DOSE OF ORAL ANTICOAGULANT - A PROSPECTIVE RANDOMIZED STUDY
Authors: SOUTO JC OLIVER A ZUAZUJAUSORO I VIVES A FONTCUBERTA J
Citation: Jc. Souto et al., ORAL-SURGERY IN ANTICOAGULATED PATIENTS WITHOUT REDUCING THE DOSE OF ORAL ANTICOAGULANT - A PROSPECTIVE RANDOMIZED STUDY, Journal of oral and maxillofacial surgery, 54(1), 1996, pp. 27-32
INFLUENZA IMMUNIZATION IS A SAFE PROCEDURE IN PATIENTS UNDERGOING LONG-TERM ANTICOAGULATION
Authors: SOUTO JC OLIVER A MONTSERRAT I MATEO J SUREDA A FONTCUBERTA J
Citation: Jc. Souto et al., INFLUENZA IMMUNIZATION IS A SAFE PROCEDURE IN PATIENTS UNDERGOING LONG-TERM ANTICOAGULATION, Archives of internal medicine, 156(14), 1996, pp. 1589
CONGENITAL HISTIDIN-RICH GLYCOPROTEIN DEFICIENCY AND FAMILIAL THROMBOPHILIA - A NEW CASE
Authors: SOUTO JC GARF M MATEO J FALKOM L BORRELL M FONTCUBERTA J
Citation: Jc. Souto et al., CONGENITAL HISTIDIN-RICH GLYCOPROTEIN DEFICIENCY AND FAMILIAL THROMBOPHILIA - A NEW CASE, Thrombosis and haemostasis, 73(6), 1995, pp. 952-952
A SINGLE-POINT MUTATION-1,691 G-]A IN BLOOD-COAGULATION FACTOR-V IN 12 PATIENTS WITH RESISTANCE TO ACTIVATED PROTEIN-C
Authors: TIRADO I LLOBET D SORIA JM SOUTO JC VALLVE C DELRIO E BORRELL M SALA N FONTCUBERTA J
Citation: I. Tirado et al., A SINGLE-POINT MUTATION-1,691 G-]A IN BLOOD-COAGULATION FACTOR-V IN 12 PATIENTS WITH RESISTANCE TO ACTIVATED PROTEIN-C, Thrombosis and haemostasis, 73(6), 1995, pp. 1126-1126
PROTHROMBOTIC STATE AND SIGNS OF ENDOTHELIAL LESION IN PLASMA OF PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
Authors: SOUTO JC MARTINEZ E ROCA M MATEO J PUJOL J GONZALEZ D FONTCUBERTA J
Citation: Jc. Souto et al., PROTHROMBOTIC STATE AND SIGNS OF ENDOTHELIAL LESION IN PLASMA OF PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, Digestive diseases and sciences, 40(9), 1995, pp. 1883-1889
ANTIPHOSPHOLIPID ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE
Authors: SOUTO JC BORRELL M FONTCUBERTA J ROCA M
Citation: Jc. Souto et al., ANTIPHOSPHOLIPID ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE, Digestive diseases and sciences, 40(7), 1995, pp. 1524-1525
LOW-LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PATIENTS WITHINFLAMMATORY BOWEL-DISEASE
Authors: SOUTO JC MARTINEZ E ROCA M MATEO J PUJOL J CONDOMINES J GONZALEZ D FONTCUBERTA J
Citation: Jc. Souto et al., LOW-LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN PATIENTS WITHINFLAMMATORY BOWEL-DISEASE, Fibrinolysis, 8(6), 1994, pp. 359-363
PLASMATIC STUDY OF FIBRINOLYSIS AND ENDOTHELIAL LESION MARKERS IN INFLAMMATORY BOWEL-DISEASE (IBD)
Authors: SOUTO JC GONZALEZ D CONDOMINES J MARTINEZ E MATEO J FONTCUBERTA J
Citation: Jc. Souto et al., PLASMATIC STUDY OF FIBRINOLYSIS AND ENDOTHELIAL LESION MARKERS IN INFLAMMATORY BOWEL-DISEASE (IBD), Thrombosis and haemostasis, 69(6), 1993, pp. 831-831
PROTHROMBOTIC STATE IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS
Authors: SOUTO JC ROCA M PUJOL J LLOBET D BORRELL M FONTCUBERTA J
Citation: Jc. Souto et al., PROTHROMBOTIC STATE IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1063-1063
Risultati: 1-25 | 26-27